Palwa, Nadia M.
HRN: 14-37-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2025
DOXYCYCLINE 100MG (CAP)
03/26/2025
03/29/2025
ORAL
100 Mg
Q12 Hours
Uterine Involution
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes